Bortezomib Mylan 3.5 mg powder for solution for injection
*Company:
Gerard LaboratoriesStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 31 August 2023
File name
pil-combined-nl4174-v014-015-clean.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
- Change to name of medicinal product
Updated on 10 November 2022
File name
ie-pl-nl4174-v013-clean.pdf
Reasons for updating
- Change to name of medicinal product
Updated on 09 March 2022
File name
ie-pl-nl4174-v012g-clean.pdf
Reasons for updating
- New PIL for new product
Updated on 09 March 2022
File name
ie-spc-nl4174-v012g-clean.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)